CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Luis Andrade graduated in Medicine at Universidade Federal de Minas Gerais (1980), has medical residency in Internal Medicine at Universidade de Sao Paulo, Ribeirão Preto (1982), and in Rheumatology at Escola Paulista de Medicina (1984). He obtained the PhD degree in Medicine in 1987. He has post-doctoral research training in molecular biology of autoantigens at Scripps Research Institute, La Jolla, California from 1989 to 1991. He obtained the degree of Professor of Medicine (Livre-Docente) at EPM-UNIFESP in 1995 and the degree of Specialist in Clinical Pathology in 2005. He is Associate Professor of the Rheumatology Division at UNIFESP and the Head of the Immuno-Rheumatology Laboratory at this institution. From 2010 to 2015 he held the position of Chair of the Autoantibody Standardization Committee affiliated to the International Union of Immunology Societies (IUIS). Since 2014 he is the coordinator of the International Consensus on ANA Patterns (ICAP). Since 2011, he is member of the European Autoantibody Standardizing Initiative (EASI). He is member of the Advisory Board Medicine II at the National Funding Agency CAPES. In 2017, he was nominated chairman of the IUIS Quality Assessment and Standardization Committee. He has experience in Medicine, focusing on Rheumatology and Autoimmunity, acting on the following subjects: auto-antibodies, autoimmunity, interface between immunodeficiency and autoimmunity, systemic lupus erythematosus, systemic sclerosis, capillaroscopy, gene expression and gene polymorphism. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Introduction: Several immunologic abnormalities reported in Systemic Lupus Erythematosus (SLE) have been reported, including abnormalities in the frequency and function of the various lymphocyte subsets, Complement system, and regulation of immunoglobulins. Recently, we have demonstrated that 28% of SLE patients present decreased IgM and IgG subclass serum levels, suggesting a subclinical…
The test ANA (antinuclear antibody) or autoantibodies against cellular antigens is one of the major tests used to identify autoantibodies. One of the challenges of clinical practice in lupus patients is the monitoring of disease activity, since it is necessary to differentiate the activity itself of chronic lesions in organs, manifestations of other disorders, infections, adverse effects …
(Only some records are available in English at this moment)
Research into Antinuclear Antibody-HEp-2 Test (ANA / HEp-2) is an important pillar for the diagnosis of various autoimmune rheumatic diseases (ARDs). The title and fluorescence pattern obtained with a given sample is important for a correct interpretation of the test. The ANA / HEp-2 test has high sensitivity, being able to identify autoantibodies not only in patients with ARDs, but also …
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by presenting various clinical, laboratory and immunological manifestations, etiology remains unknown. It is estimated that at least 50% of SLE patients will suffer an episode of severe infection in the course of their disease and infections carry significant morbidity and mortality in patients of SLE patient…
The immune system is composed of many cells and molecules capable of recognizing and eliminating foreign elements to maintaining homeostasis. These mechanisms work together to play an efficient broad protective function that's cell-mediated, soluble mediators and their receptors. Among these important receptors for regulation and proper function of the immune system we can cite TACI. TACI…
(Only some records are available in English at this moment)
| 34 / 12 | Completed research grants |
| 18 / 9 | Completed scholarships in Brazil |
| 52 / 21 | All research grants and scholarships |
| Associated processes | |